Description BPC-157, an abbreviation for Body Protection Compound-157, derives from body protection compound (BPC), a protein naturally occurring in the human digestive tract
Even with all the appropriate precautions, injection site irritations such as redness, swelling, or pain are common
The compound suppresses fibrinogen expression (linked to cardiovascular risk) and reduces TGF-beta-driven fibrosis signaling
The reconstitution and administration of injectable medicines in the UK must be performed by, or under the direct supervision of, a qualified healthcare professional, following the product's SmPC and in accordance with NHS and NPSA guidance on the safer use of injectable medicines
Cagrilintide is a synthetic peptide analog of amylin